Functional Capacity of Human Islets After Long-Distance Shipment and Encapsulation
Authors:
- 1 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 40 (2) , 247-252
Abstract
Objective: Human islets produced at an isolation center are shipped to researchers, usually taking short periods to arrive at their destination. In this study, we investigated whether human islets after long-distance shipment across the Pacific Ocean for 2 to 3 days and encapsulation could maintain their functionality. Methods: Human islets were encapsulated in alginate and viability assessed using carboxyfluorescein diacetate and propidium iodide. Stimulation index after static glucose incubation was calculated. Streptozotocin-induced diabetic nonobese diabetic/severe combined immunodeficient mice were transplanted with 3000, 2000, or 1000 islet equivalents of nonencapsulated and encapsulated islets and glucose levels monitored. When levels were normal, the graft was retrieved and assessed. Results: Viability of human islets was unaltered after long-distance shipment with a retrieval rate of 88.3% +/- 1.9%. After encapsulation, the viability was unchanged (before encapsulation 86.1% +/- 0.7% vs after encapsulation 80.8 +/- 0.7%) at 11 days after isolation. Function in vitro of nonencapsulated and encapsulated islets was unaffected with a stimulation index of 2.2 and 1.9, respectively. Euglycemia was achieved in 100% mice receiving 2000 and 3000 islet equivalents of nonencapsulated and encapsulated islets, respectively. Capsules retrieved after transplantation was intact, free floating, and contained viable islets. Conclusion: Human islets can be shipped safely for long distances without compromising viability and function even after encapsulation and culture.Keywords
This publication has 19 references indexed in Scilit:
- Safety and Viability of Microencapsulated Human Islets Transplanted Into Diabetic HumansDiabetes Care, 2009
- Islet cell transplantationCurrent Opinion in Organ Transplantation, 2008
- Survival of Microencapsulated Islets at 400 Days Posttransplantation in the Omental Pouch of NOD MiceCell Transplantation, 2006
- Microencapsulated Pancreatic Islet Allografts Into Nonimmunosuppressed Patients With Type 1 DiabetesDiabetes Care, 2006
- ISLETS IN ALGINATE MACROBEADS REVERSE DIABETES DESPITE MINIMAL ACUTE INSULIN SECRETORY RESPONSES1Transplantation, 2001
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?Diabetes, 1999
- Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression.Journal of Clinical Investigation, 1996
- Host Reaction against Alginate-polylysine Microcapsules Containing Living CellsJournal of Pharmacy and Pharmacology, 1993
- Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membraneBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1984